Migraine is not an adult condition that occasionally affects younger people. It is one of the most common neurological disorders in children and adolescents, affecting approximately ten percent of school-age children and up to twenty-eight percent of teenagers. It is a leading cause of school absence, disrupted social development, and pediatric disability. And it is frequently unrecognized, misattributed to other causes, or dismissed by adults who assume that children cannot have real migraines.
Understanding how migraine presents in younger people, how it differs from adult migraine, and what safe and effective treatment options exist changes the outcomes for children and teenagers who are living with a condition that has significant impacts on their daily functioning and quality of life.
Several features of migraine in children and teenagers differ meaningfully from the adult presentation.
The pain is more commonly bilateral in children than in adults. While adult migraine typically presents with unilateral, throbbing pain, pediatric migraine often involves pain on both sides of the head. This can lead to misidentification as tension headache.
Attacks are typically shorter in children than in adults. While adult migraine attacks last four to seventy-two hours without treatment, pediatric attacks may resolve in as little as one to two hours. The International Headache Society diagnostic criteria for migraine without aura in children acknowledge this difference by applying a minimum attack duration of two hours rather than four.
Associated symptoms are often more prominent relative to the headache in children. Nausea, vomiting, abdominal pain, and pallor during attacks are frequently reported and may be the most distressing features of the attack for young patients.
Several migraine-related syndromes are particularly common in children and may represent early manifestations of migraine.
Abdominal migraine produces recurrent episodes of midline abdominal pain with nausea, vomiting, and pallor that resolve spontaneously and occur in the absence of gastrointestinal pathology. It is associated with a family history of migraine and frequently evolves into typical migraine headache in adolescence.
Cyclic vomiting syndrome produces stereotyped episodes of severe nausea and vomiting that occur at regular intervals and resolve completely between episodes. Like abdominal migraine, it is associated with migraine and responds to some of the same treatments.
Benign paroxysmal vertigo of childhood produces sudden episodes of vertigo in young children who appear frightened and unsteady but remain conscious and without headache. This syndrome is considered a migraine precursor.
Diagnosing migraine in children requires the same careful headache history that is the foundation of adult diagnosis, adapted for the age and communication abilities of the patient. Asking children to point to where their head hurts, to describe whether the pain feels like a hammer or a throb, and to show how bad it is on a scale that uses faces or numbers rather than purely verbal descriptors can produce more useful information.
A prospective headache diary, kept by the child with parental assistance where needed, is as valuable in pediatric migraine as in adult migraine.
Ibuprofen and acetaminophen are the first-line acute treatments for migraine in children and have evidence from clinical trials in pediatric populations. Ibuprofen is generally considered more effective than acetaminophen for acute migraine pain in children who are old enough to tolerate it.
Sumatriptan nasal spray is the triptan with the most evidence in adolescent migraine and is approved for use in people aged twelve and older in some countries. Anti-nausea medications including ondansetron and prochlorperazine are used for attacks with prominent vomiting.
Preventive treatment should be considered for children with frequent attacks that significantly disrupt school attendance, sleep, and social functioning.
A large randomized trial published in the New England Journal of Medicine found that amitriptyline, topiramate, and placebo produced similar reductions in monthly headache days in children and adolescents with migraine, suggesting that some of the benefit of these medications in pediatric populations may involve placebo response and non-specific effects. This finding has led to increased interest in behavioral and lifestyle interventions as primary prevention strategies in children.
Behavioral interventions including cognitive behavioral therapy, biofeedback, and relaxation training have evidence for efficacy in pediatric migraine and are considered first-line preventive approaches by many pediatric headache specialists.
Migraine in children and teenagers affects not just the individual but the school and family environment. A school accommodation plan, formally known as a 504 plan in the United States, can provide accommodations including permission to take medication at school, access to a quiet rest area during attacks, and allowances for attendance impacts.
Parental response to migraine attacks influences how children cope with the condition over time. Research has found that high levels of parental solicitousness are associated with higher disability in pediatric migraine. A balance between acknowledging the child's pain and maintaining normal functioning expectations where possible supports better long-term outcomes.
Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology. 2001.
Powers SW, Coffey CS, Chamberlin LA, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. New England Journal of Medicine. 2017.
International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018.
American Migraine Foundation. Migraine in Children. americanmigrainefoundation.org
How pregnancy affects migraine, which medications are relatively safe, which to avoid, and the importance of planning before and during pregnancy.
How migraine frequency and character change with age, medication considerations for older adults, comorbidities, and hormone therapy.
The evidence for mindfulness-based stress reduction, relaxation training, and biofeedback — and how they compare to pharmacological prevention.
Magnesium, riboflavin, coenzyme Q10, omega-3 fatty acids, and dietary patterns — what clinical trial evidence actually supports.
Tracking your migraines changes everything. MigraClarity helps you log attacks, identify triggers, monitor medications, and track sleep and hydration — then generates a provider-ready report you can bring to your next appointment. Create your free account and start building a clearer picture of your migraine pattern today.
Create Your Free AccountThe information in this article is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional or licensed physician before making any decisions about your health, medications, or treatment. MigraClarity is not a medical provider and nothing on this site should be used as a substitute for professional medical care.